iRhythm price target raised to $170 from $139 at Canaccord

Canaccord analyst William Plovanic raised the firm’s price target on iRhythm (IRTC) to $170 from $139 and keeps a Buy rating on the shares. The firm said they delivered a rock-solid beat and raise in the core business with its early detection strategy coming into form and the company raising its FY25 revenue and adjusted EBITDA due to strong Zio Monitor performance.